Valproic acid Recruiting Phase 2 Trials for Myelodysplastic Syndrome MDS / Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02124174Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS